210. 単心室症 Single Ventricle Clinical trials / Disease details
臨床試験数 : 49 / 薬物数 : 53 - (DrugBank : 23) / 標的遺伝子数 : 32 - 標的パスウェイ数 : 67
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT02946892 (ClinicalTrials.gov) | November 2016 | 23/9/2016 | Effect of Carvedilol on Exercise Performance in Fontan Patients | Effect of Carvedilol on Exercise Performance in Fontan Patients | Single Ventricle;Fontan | Drug: Carvedilol;Drug: Placebo | University of Texas Southwestern Medical Center | American Heart Association | Completed | 10 Years | 35 Years | All | 26 | Phase 4 | United States |